MCID: MTR003
MIFTS: 45

Mitral Valve Stenosis

Categories: Cardiovascular diseases

Aliases & Classifications for Mitral Valve Stenosis

MalaCards integrated aliases for Mitral Valve Stenosis:

Name: Mitral Valve Stenosis 12 44 15 73
Mitral Stenosis 12 29 55
Rheumatic Mitral Stenosis 73

Classifications:



External Ids:

Disease Ontology 12 DOID:1754
MeSH 44 D008946
NCIt 50 C50654
ICD10 33 I05.0 I05.2

Summaries for Mitral Valve Stenosis

Disease Ontology : 12 A mitral valve disease that is characterized by the narrowing of the orifice of the mitral valve of the heart.

MalaCards based summary : Mitral Valve Stenosis, also known as mitral stenosis, is related to heparin-induced thrombocytopenia and pericardial effusion. An important gene associated with Mitral Valve Stenosis is NPPB (Natriuretic Peptide B), and among its related pathways/superpathways are amb2 Integrin signaling and Glypican 1 network. The drugs Dobutamine and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include heart, neutrophil and monocytes, and related phenotypes are Decreased substrate adherent cell growth and Decreased substrate adherent cell growth

Wikipedia : 76 Mitral stenosis is a valvular heart disease characterized by the narrowing of the orifice of the mitral... more...

Related Diseases for Mitral Valve Stenosis

Diseases related to Mitral Valve Stenosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 70)
# Related Disease Score Top Affiliating Genes
1 heparin-induced thrombocytopenia 30.6 SELP SERPINC1
2 pericardial effusion 30.2 NPPA NPPB
3 tricuspid valve stenosis 29.7 BUB1B CRELD1
4 atrial fibrillation 29.5 NPPA NPPB PF4 SELP
5 coronary artery anomaly 29.3 NPPA NPPB PF4 SELP
6 heart disease 29.2 ATP2A2 CRELD1 NPPA NPPB SERPINC1
7 arteries, anomalies of 28.7 ACVRL1 NPPB SELP SERPINC1
8 pulmonary hypertension 28.2 ACVRL1 NPPA NPPB PF4 SERPINC1
9 mitral valve insufficiency 27.5 CEP57 CRELD1 HCK NPPA NPPB SAMHD1
10 congenital mitral stenosis 12.3
11 central sleep apnea 10.7 NPPA NPPB
12 syndrome of inappropriate antidiuretic hormone 10.6 NPPA NPPB
13 idiopathic edema 10.6 NPPA NPPB
14 syncope 10.6 NPPA NPPB
15 hyperhidrosis, gustatory 10.6 ATP2A2 HCK
16 mitral atresia 10.6
17 korean hemorrhagic fever 10.6 NPPA SERPINC1
18 retinal vascular occlusion 10.5 SELP SERPINC1
19 ebstein anomaly 10.5 CRELD1 NPPB
20 legg-calve-perthes disease 10.5 SELP SERPINC1
21 intermediate coronary syndrome 10.4 SELP SERPINC1
22 portal vein thrombosis 10.4 SELP SERPINC1
23 cold urticaria 10.3 PF4 SERPINC1
24 mosaic variegated aneuploidy syndrome 10.3 BUB1B CEP57
25 intermittent claudication 10.3 SELP SERPINC1
26 patent ductus arteriosus 1 10.2 CRELD1 NPPB
27 aortic valve disease 2 10.2 HCK NPPA NPPB
28 anomalous left coronary artery from the pulmonary artery 10.2 CRELD1 PF4
29 tetralogy of fallot 10.1 CRELD1 NPPA NPPB
30 cardiac tamponade 10.0 ACVRL1 NPPB
31 platelet aggregation, spontaneous 10.0 PF4 SELP SERPINC1
32 blood coagulation disease 10.0 PF4 SELP SERPINC1
33 blood platelet disease 10.0 PF4 SELP SERPINC1
34 systemic lupus erythematosus 10.0
35 rheumatic heart disease 10.0
36 endocarditis 10.0
37 lupus erythematosus 10.0
38 aortic coarctation 10.0
39 acute myocardial infarction 9.9 NPPA NPPB SELP SERPINC1
40 paralytic squint 9.9 HCK SAMHD1
41 stroke, ischemic 9.8 PF4 SELP SERPINC1
42 poland syndrome 9.8
43 lung cancer 9.8
44 pulmonary arteriovenous fistulas 9.8
45 anxiety 9.8
46 muscle hypertrophy 9.8
47 arteriovenous fistula 9.8
48 thrombocytopenia 9.8
49 angiosarcoma 9.8
50 infective endocarditis 9.8

Comorbidity relations with Mitral Valve Stenosis via Phenotypic Disease Network (PDN): (show all 19)


Acute Cystitis Aortic Valve Disease 1
Bronchitis Chronic Myocardial Ischemia
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Hypothyroidism
Intermediate Coronary Syndrome Intracranial Embolism
Ischemic Heart Disease Mitral Valve Disease
Pulmonary Hypertension, Primary, 1 Respiratory Failure
Rheumatic Heart Disease Rheumatic Myocarditis
Sinoatrial Node Disease Transient Cerebral Ischemia
Tricuspid Valve Disease

Graphical network of the top 20 diseases related to Mitral Valve Stenosis:



Diseases related to Mitral Valve Stenosis

Symptoms & Phenotypes for Mitral Valve Stenosis

GenomeRNAi Phenotypes related to Mitral Valve Stenosis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased substrate adherent cell growth GR00193-A-1 9.35 ACVRL1 BUB1B HCK
2 Decreased substrate adherent cell growth GR00193-A-2 9.35 BUB1B
3 Decreased substrate adherent cell growth GR00193-A-4 9.35 ACVRL1
4 Paclitaxel antagonistic effect GR00113-A-0 8.62 BUB1B HCK

MGI Mouse Phenotypes related to Mitral Valve Stenosis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.76 ACVRL1 ATP2A2 BUB1B CRELD1 HCK NPPA
2 hematopoietic system MP:0005397 9.56 BUB1B HCK NPPA PF4 SELP SERPINC1
3 renal/urinary system MP:0005367 9.02 ACVRL1 ATP2A2 NPPA SELP SERPINC1

Drugs & Therapeutics for Mitral Valve Stenosis

Drugs for Mitral Valve Stenosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 46)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dobutamine Approved Phase 4 34368-04-2 36811
2
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
3
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
4
Norepinephrine Approved Phase 4 51-41-2 439260
5
Racepinephrine Approved Phase 4 329-65-7 838
6
Warfarin Approved Phase 4 81-81-2 6691 54678486
7
Serine Approved, Nutraceutical Phase 4 56-45-1 5951
8 Simendan Investigational Phase 4 131741-08-7
9 Anticoagulants Phase 4
10 Antithrombin III Phase 4
11 Antithrombins Phase 4
12 HIV Protease Inhibitors Phase 4
13
protease inhibitors Phase 4
14 Serine Proteinase Inhibitors Phase 4
15 Adrenergic Agents Phase 4,Phase 3
16 Adrenergic Agonists Phase 4
17 Adrenergic beta-Agonists Phase 4
18 Anti-Arrhythmia Agents Phase 4,Phase 3
19 Autonomic Agents Phase 4,Phase 3
20 Dopamine Agents Phase 4
21 Epinephryl borate Phase 4
22 Neurotransmitter Agents Phase 4,Phase 3
23 Peripheral Nervous System Agents Phase 4,Phase 3
24 Phosphodiesterase Inhibitors Phase 4
25 Protective Agents Phase 4
26 Vasodilator Agents Phase 4
27 Dabigatran Phase 4
28 Calamus Nutraceutical Phase 4
29
Atenolol Approved Phase 3 29122-68-7 2249
30 Antihypertensive Agents Phase 3,Phase 1,Phase 2
31 Adrenergic Antagonists Phase 3
32 Adrenergic beta-1 Receptor Antagonists Phase 3
33 Adrenergic beta-Antagonists Phase 3
34 Sympatholytics Phase 3
35
Bosentan Approved, Investigational Phase 1, Phase 2 147536-97-8 104865
36 Endothelin Receptor Antagonists Phase 1, Phase 2
37
Menthol Approved Not Applicable 2216-51-5 16666
38
Cabergoline Approved 81409-90-7 54746
39
Levodopa Approved 59-92-7 6047
40
Sevoflurane Approved, Vet_approved 28523-86-6 5206
41 Dopamine agonists
42 Anesthetics
43 Anesthetics, General
44 Anesthetics, Inhalation
45 Central Nervous System Depressants
46 Platelet Aggregation Inhibitors

Interventional clinical trials:

(show all 45)
# Name Status NCT ID Phase Drugs
1 Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery Unknown status NCT01201070 Phase 4 antithrombin III
2 The Effects of Levosimendan During Mitral Valve Surgery Completed NCT01969071 Phase 4 Levosimendan;Dobutamine
3 Beating Versus Arrested Heart for Mitral Valve Replacement Completed NCT01641614 Phase 4
4 Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses Enrolling by invitation NCT03183843 Phase 4 Dabigatran Etexilate;Warfarin
5 Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm Completed NCT01022463 Phase 3 Ivabradine;Atenolol
6 Bosentan for Severe Mitral Valve Dysfunction Unknown status NCT01270750 Phase 1, Phase 2 BOSENTAN
7 Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery Completed NCT00903370 Phase 2
8 Feasibility Study of a Percutaneous Mitral Valve Repair System. Completed NCT00209339 Phase 1, Phase 2
9 Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification (SITRAL) Study Recruiting NCT02830204 Phase 1, Phase 2
10 NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation Enrolling by invitation NCT03015194 Phase 2
11 Ablation of the Pulmonary Artery With High Pulmonary Hypertension During Mitral Valve Surgery Unknown status NCT02374229 Phase 1
12 Mitral Implantation of TRAnscatheter vaLves Active, not recruiting NCT02370511 Phase 1
13 Mitral Valve Area Assessment: Comparison With Transthoracic Echocardiography and Magnetic Resonance Imaging Unknown status NCT00654472
14 Non-invasive Characterization of the Mechanisms of Atrial Fibrillation Maintenance Unknown status NCT02497248
15 Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region Completed NCT02188862
16 Mitral Valve Area Using 3-dimensional Transesophageal Echocardiography Completed NCT01694251
17 Balloon Valvuloplasty Registry Completed NCT00005199
18 Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery Completed NCT02831270 hydroxyethyl starch (HES 130/0.6)
19 Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery Completed NCT02502448 Not Applicable hydroxyethyl starch (HES 130/0.6)
20 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Completed NCT00636987 Not Applicable
21 Teledi@Log - Tele-rehabilitation of Heart Patients Completed NCT01752192 Not Applicable
22 Logical Analysis of Data and Cardiac Surgery Risk Completed NCT00081666
23 ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES) Completed NCT02344901
24 EVEREST II Pivotal Study High Risk Registry (HRR) Completed NCT01940120 Not Applicable
25 Physical and Functional Recovery From Cardiac Surgery in Hospitalized Patients: A Feasibility Pilot Study Completed NCT02375282 Not Applicable
26 Pivotal Study of a Percutaneous Mitral Valve Repair System Completed NCT00209274 Not Applicable
27 Rheumatic Heart Disease in Peru: Prevalence and Cardiovascular Outcomes Among Schoolchildren Completed NCT02353663
28 The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events Completed NCT01052948
29 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe Completed NCT01288976 Medical Management
30 French National Observatory of Percutaneous Mitral Commissurotomy Recruiting NCT02783248
31 The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2 Recruiting NCT02552771 Not Applicable
32 Annular Reshaping of the Mitral Valve for MR Using the Millipede IRIS System Recruiting NCT02607527 Not Applicable
33 Determine the Effective Dose 95 of Sevoflurane in Adult Patients Recruiting NCT02711384
34 Phono- and Electrocardiogram Assisted Detection of Valvular Disease Recruiting NCT03458806
35 Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery Recruiting NCT02925819
36 Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) Recruiting NCT01626079 Not Applicable
37 HighLife™ Transcatheter Mitral Valve Replacement System Study Recruiting NCT02974881 Not Applicable
38 European Feasibility Study of High Surgical Risk Patients With Severe Mitral Regurgitation Treated With the Cardiovalve Transfemoral Mitral Valve System Recruiting NCT03339115 Not Applicable
39 Early Percutaneous Mitral Intervention in Asymptomatic Moderate Mitral Stenosis Active, not recruiting NCT01406353 Not Applicable
40 Post-Approval Study for the MOSAIC® Bioprostheses Active, not recruiting NCT01574625
41 AVJ-514 Japan Trial Active, not recruiting NCT02520310 Not Applicable
42 ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) Active, not recruiting NCT01757665 Not Applicable
43 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Active, not recruiting NCT01931956 Not Applicable
44 Silent Atrial Fibrillation in Patients With Mitral Stenosis and Sinus Rhythm and Its Correlation Left Atrial Thrombus Not yet recruiting NCT03505073
45 Mitral Annuloplasty Rings RCT Not yet recruiting NCT03290872 Not Applicable

Search NIH Clinical Center for Mitral Valve Stenosis

Cochrane evidence based reviews: mitral valve stenosis

Genetic Tests for Mitral Valve Stenosis

Genetic tests related to Mitral Valve Stenosis:

# Genetic test Affiliating Genes
1 Mitral Stenosis 29

Anatomical Context for Mitral Valve Stenosis

MalaCards organs/tissues related to Mitral Valve Stenosis:

41
Heart, Neutrophil, Monocytes, Lung, Lymph Node

Publications for Mitral Valve Stenosis

Articles related to Mitral Valve Stenosis:

(show top 50) (show all 151)
# Title Authors Year
1
Mitral Valve Stenosis: Still a Clinical Challenge? ( 29772580 )
2018
2
Repair for Congenital Mitral Valve Stenosis. ( 29425525 )
2018
3
Association of lymphocyte-monocyte ratio and monocyte-to-high-density lipoprotein ratio with the presence and severity of rheumatic mitral valve stenosis. ( 28770612 )
2017
4
Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary? ( 28222495 )
2017
5
Transapical Mitral Valve Implantation for Native Mitral Valve Stenosis Using a Balloon-Expandable Prosthesis. ( 28760473 )
2017
6
Rapidly progressive mitral valve stenosis in patients with acromelic dysplasia. ( 28077185 )
2017
7
Evaluation of Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with mitral valve stenosis before and after balloon valvuloplasty. ( 29044094 )
2017
8
Surgical results of mitral valve repair for congenital mitral valve stenosis in paediatric patients. ( 29106557 )
2017
9
Infective endocarditis causing mitral valve stenosis - a rare but deadly complication: a case report. ( 28209176 )
2017
10
Conventional Surgery For Early and Late Symptomatic Mitral Valve Stenosis After MitraClip(Ar) Intervention: An Institutional Experience With Four Consecutive Patients. ( 28286089 )
2017
11
The clinical challenge of concomitant aortic and mitral valve stenosis. ( 26853247 )
2016
12
Potential benefits of exercise training in rheumatic severe mitral valve stenosis in a heavy trainer. ( 27390992 )
2016
13
Development of a Severe Mitral Valve Stenosis Secondary to the Treatment of Mitral Regurgitation with a Single MitraClip. ( 26805917 )
2016
14
Triple Percutaneous Mitral Balloon Valvuloplasty for Patients with Recurrent Mitral Valve Stenosis: Long-Term Observations. ( 27989086 )
2016
15
The Presence of Left Atrial Thrombus is Associated with the Neutrophil-to-Lymphocyte Ratio in Patients with Rheumatic Mitral Valve Stenosis. ( 27989067 )
2016
16
Massive mitral valve thrombosis following reversal of warfarin in a patient with rheumatic mitral valve stenosis. ( 27464842 )
2016
17
Severe Bioprosthetic Mitral Valve Stenosis and Heart Failure in a Young Woman with Systemic Lupus Erythematosus. ( 27610249 )
2016
18
Mitral Valve Stenosis after Open Repair Surgery for Non-rheumatic Mitral Valve Regurgitation: A Review. ( 27148540 )
2016
19
Evidence of apoptosis in right ventricular dysfunction in rheumatic mitral valve stenosis. ( 28361825 )
2016
20
Correlation between Pulmonary Artery Pressure Measured by Echocardiography and Right Heart Catheterization in Patients with Rheumatic Mitral Valve Stenosis (A Prospective Study). ( 26096532 )
2015
21
Real-time Three-dimensional Echocardiographic Assessment of Rheumatic Mitral Valve Stenosis. ( 26197046 )
2015
22
Association of pentraxin-3 with the severity of rheumatic mitral valve stenosis. ( 26455242 )
2015
23
The neutrophil to lymphocyte ratio is associated with severity of rheumatic mitral valve stenosis. ( 25999773 )
2015
24
Morphological and chemical study of pathological deposits in human aortic and mitral valve stenosis: a biomineralogical contribution. ( 25685595 )
2015
25
Review of Congenital Mitral Valve Stenosis: Analysis, Repair Techniques and Outcomes. ( 26577233 )
2015
26
Mitral Valve Stenosis Progression Due to Severe Calcification on Glutaraldehyde-Treated Autologous Pericardium: Word of Caution for an Attractive Repair Technique. ( 26046878 )
2015
27
2-Year Follow-Up of the First in Human Transapical Implantation of Transcatheter Inverted Aortic Valve to Treat Native Mitral Valve Stenosis. ( 26738679 )
2015
28
Impaired circadian rhythm of blood pressure in normotensive patients with rheumatic mitral valve stenosis. ( 24399183 )
2014
29
Predictive factors of left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis: a retrospective study of 159 patients. ( 24995039 )
2014
30
The evaluation of mitral valve stenosis: comparison of transthoracic echocardiography and cardiac magnetic resonance. ( 24026945 )
2014
31
Transapical mitral implantation of a balloon-expandable valve in native mitral valve stenosis in a patient with previous transcatheter aortic valve replacement. ( 25240553 )
2014
32
Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis? ( 25430404 )
2014
33
Echocardiographic estimation of left ventricular filling pressures in patients with mitral valve stenosis. ( 24626519 )
2014
34
Influenza a infection unmasking an underlying mitral valve stenosis in a 19-year-old boy. ( 24479080 )
2013
35
Double giant thrombi in the left atrium in a patient with rheumatic mitral valve stenosis and atrial fibrillation. ( 23671200 )
2013
36
Left atrium reverse remodeling in patients with mitral valve stenosis after percutaneous valvuloplasty: a 2- and 3-dimensional echocardiographic study. ( 22878092 )
2013
37
Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis. ( 23180241 )
2013
38
Left atrium reverse remodeling in patients with mitral valve stenosis after percutaneous valvuloplasty: a 2- and 3-dimensional echocardiographic study. ( 23485181 )
2013
39
Transcatheter mitral valve replacement using a balloon-expandable prosthesis in a patient with calcified native mitral valve stenosis. ( 23828829 )
2013
40
Severe mitral valve stenosis with left atrial thrombus in the puerperium: to treat or to observe? ( 24229700 )
2013
41
Anaesthetic management for caesarean section surgery in two pregnant women with severe pulmonary hypertension due to mitral valve stenosis. ( 25207156 )
2013
42
Association of Neutrophil-Lymphocyte Ratio With the Presence and Severity of Rheumatic Mitral Valve Stenosis. ( 24335245 )
2013
43
Severe bioprosthetic mitral valve stenosis in pregnancy. ( 24374988 )
2013
44
Giant left atrial myxoma mimicking severe mitral valve stenosis and severe pulmonary hypertension. ( 23601991 )
2013
45
A high risk critical mitral valve stenosis with emergency management at apollo hospitals dhaka. ( 24292322 )
2013
46
First in human transapical implantation of an inverted transcatheter aortic valve prosthesis to treat native mitral valve stenosis. ( 23918190 )
2013
47
Myocardial bridging of the left anterior descending coronary artery and right coronary artery in a patient with mitral valve stenosis. ( 22718391 )
2012
48
Giant obstructive left atrial myxoma resembling mitral valve stenosis. ( 22892935 )
2012
49
Congenital mitral valve stenosis: anatomic variants and surgical reconstruction. ( 22424510 )
2012
50
I was recently diagnosed with mitral valve stenosis. Will it improve through exercise and diet? I have no symptoms. ( 22396998 )
2012

Variations for Mitral Valve Stenosis

Expression for Mitral Valve Stenosis

Search GEO for disease gene expression data for Mitral Valve Stenosis.

Pathways for Mitral Valve Stenosis

Pathways related to Mitral Valve Stenosis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.84 HCK SELP
2 10.37 HCK SERPINC1
3 9.97 NPPA NPPB

GO Terms for Mitral Valve Stenosis

Biological processes related to Mitral Valve Stenosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to lipopolysaccharide GO:0032496 9.61 ATP2A2 PF4 SELP
2 negative regulation of cell growth GO:0030308 9.43 ACVRL1 NPPA NPPB
3 cGMP biosynthetic process GO:0006182 9.4 NPPA NPPB
4 positive regulation of heart rate GO:0010460 9.37 ATP2A2 NPPA
5 regulation of blood vessel size GO:0050880 9.32 NPPA NPPB
6 cardiac muscle hypertrophy in response to stress GO:0014898 9.16 ATP2A2 NPPA
7 receptor guanylyl cyclase signaling pathway GO:0007168 8.96 NPPA NPPB
8 regulation of blood pressure GO:0008217 8.8 ACVRL1 NPPA NPPB

Molecular functions related to Mitral Valve Stenosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 heparin binding GO:0008201 9.13 PF4 SELP SERPINC1
2 hormone receptor binding GO:0051427 8.62 NPPA NPPB

Sources for Mitral Valve Stenosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....